Home Cart 0 Sign in  
X

[ CAS No. 4857-42-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4857-42-5
Chemical Structure| 4857-42-5
Chemical Structure| 4857-42-5
Structure of 4857-42-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4857-42-5 ]

Related Doc. of [ 4857-42-5 ]

Alternatived Products of [ 4857-42-5 ]

Product Details of [ 4857-42-5 ]

CAS No. :4857-42-5 MDL No. :MFCD00464222
Formula : C5H5NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :HXIYCKAAQPHZBM-UHFFFAOYSA-N
M.W : 127.10 Pubchem ID :853085
Synonyms :

Calculated chemistry of [ 4857-42-5 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.2
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 28.43
TPSA : 63.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.63 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.97
Log Po/w (XLOGP3) : 0.63
Log Po/w (WLOGP) : 0.68
Log Po/w (MLOGP) : -0.4
Log Po/w (SILICOS-IT) : 0.65
Consensus Log Po/w : 0.51

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.37
Solubility : 5.42 mg/ml ; 0.0427 mol/l
Class : Very soluble
Log S (Ali) : -1.53
Solubility : 3.71 mg/ml ; 0.0292 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.96
Solubility : 14.0 mg/ml ; 0.11 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.27

Safety of [ 4857-42-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4857-42-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4857-42-5 ]
  • Downstream synthetic route of [ 4857-42-5 ]

[ 4857-42-5 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 4857-42-5 ]
  • [ 14716-89-3 ]
YieldReaction ConditionsOperation in experiment
56% With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 2 h; Inert atmosphere To a solution of 3-methylisoxazole-5-carboxylic acid (3 g, 23.6 mmol) in tetrahydrofuran (20 mL) was added L1AIH4 (1.8 g, 47.37 mmol) in portions at 0 °C under nitrogen atmosphere. After additional 2 hours at room temperature, the reaction was then quenched by water (2 mL). The mixture was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a residue, which was purified by a silica gel column, eluted with 10 percent - 30 percent ethyl acetate in petroleum ether to afford (3-methylisoxazol-5-yl)methanol as colorless oil (1.5 g, 56 percent); (ES, m/z) [M+H] + 114.1 ; *H NMR (300 MHz, CDC13) δ 6.09 (s, 1H), 4.74 (s, 2H), 2.30 (s, 3H), 2.10 (brs, 1H).
Reference: [1] Patent: WO2014/66795, 2014, A1, . Location in patent: Paragraph 0175
[2] Patent: WO2016/97870, 2016, A1,
[3] ChemMedChem, 2017, vol. 12, # 1, p. 50 - 65
  • 2
  • [ 20577-61-1 ]
  • [ 3405-77-4 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1942, vol. 72, p. 411,422
[2] Journal of the American Pharmaceutical Association (1912-1977), 1953, vol. 42, p. 594,597
  • 3
  • [ 7803-49-8 ]
  • [ 615-79-2 ]
  • [ 3405-77-4 ]
  • [ 4857-42-5 ]
Reference: [1] Chemische Berichte, 1891, vol. 24, p. 3908[2] Chemische Berichte, 1909, vol. 42, p. 60
  • 4
  • [ 67-56-1 ]
  • [ 4857-42-5 ]
  • [ 1004-96-2 ]
YieldReaction ConditionsOperation in experiment
76% at 0 - 40℃; for 3.25 h; To a solution of compound 9 (1 g, 7.9 mmoi, 1.0 eq) in dry MeOH (20 mi.) was added SOCI2 (1 g, 8,7 mmol, 1.1 eq) slowly at 0 °C. The reaction mixture was stirred at 25 °C for 15 min and heated to 40 °C for 3 h. The reaction mixture was concentrated under reduced pressure, dissolved in EtOAc (50 mL), washed with brine (2 x 50 mL), dried over anhydrous Na2SOa, filtered and concentrated in vacuum. The residue was purified by column chromatography (0-20percent EtOAc in PE) to afford 10 (850 mg, 6.0 mmol, 76percent yield) as a white solid: JH NM (400 M Hz, CDCI3) δ 2.40 (s, 3H), 3.98 (s, 3H), 6.82 (s, 1H).
Reference: [1] Patent: WO2016/97870, 2016, A1, . Location in patent: Paragraph 0165
  • 5
  • [ 63366-79-0 ]
  • [ 4857-42-5 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: With sodium hydroxide; water In tetrahydrofuran; methanol at 20℃; for 18 - 20 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; methanol; water
A round bottom flask with magnetic stirrer was charged with 3-methyl-isoxazole-5- carboxylic acid ethyl ester (900 mg, 5.8 mmol) in tetrahydrofuran (2.0 mL). To the reaction was added a solution of sodium hydroxide (465 mg, 11.6 mmol) in water (2 mL), followed by methanol (4 mL). The reaction was stirred at room temperature for 18 - 20 hours under an argon atmosphere. The reaction was transferred to a separatory funnel and the pH adjusted to 2 via addition of IN hydrochloric acid. The mixture was extracted with ethyl acetate (3 x 35 mL) and the combined extractions were washed with brine (1 x 50 mL), dried over magnesium sulfate, and filtered. The filtrate was concentrated in vacuo to yield S-methyl-isoxazole-S-carboxylic acid as a white solid (660 mg, 90percent). The solid was used without purification in the next reaction.
Reference: [1] Angewandte Chemie - International Edition, 2016, vol. 55, # 29, p. 8353 - 8357[2] Angew. Chem., 2016, vol. 128, # 29, p. 8493 - 8497,5
[3] Patent: WO2006/91674, 2006, A1, . Location in patent: Page/Page column 79
[4] European Journal of Medicinal Chemistry, 1992, vol. 27, # 6, p. 581 - 593
  • 6
  • [ 14716-89-3 ]
  • [ 4857-42-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9008 - 9018
  • 7
  • [ 135351-18-7 ]
  • [ 4857-42-5 ]
Reference: [1] Tetrahedron Letters, 2000, vol. 41, # 3, p. 293 - 297
[2] Tetrahedron Letters, 2000, vol. 41, # 3, p. 293 - 297
  • 8
  • [ 135351-22-3 ]
  • [ 4857-42-5 ]
Reference: [1] Canadian Journal of Chemistry, 2005, vol. 83, # 8, p. 1171 - 1177
  • 9
  • [ 93904-13-3 ]
  • [ 4857-42-5 ]
Reference: [1] Chemical and pharmaceutical bulletin, 1962, vol. 10, p. 607 - 611
  • 10
  • [ 7063-93-6 ]
  • [ 4857-42-5 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1966, vol. 2, p. 414 - 420[2] Zhurnal Organicheskoi Khimii, 1966, vol. 2, p. 417 - 423
  • 11
  • [ 13608-39-4 ]
  • [ 4857-42-5 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1966, vol. 2, p. 1736 - 1739[2] Zhurnal Organicheskoi Khimii, 1966, vol. 2, p. 1766 - 1769
  • 12
  • [ 615-79-2 ]
  • [ 4857-42-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2016, vol. 55, # 29, p. 8353 - 8357[2] Angew. Chem., 2016, vol. 128, # 29, p. 8493 - 8497,5
  • 13
  • [ 135351-33-6 ]
  • [ 4857-42-5 ]
Reference: [1] Tetrahedron Letters, 2000, vol. 41, # 3, p. 293 - 297
  • 14
  • [ 94165-54-5 ]
  • [ 4857-42-5 ]
Reference: [1] Chemical and pharmaceutical bulletin, 1962, vol. 10, p. 607 - 611
  • 15
  • [ 70753-36-5 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1942, vol. 72, p. 99,106
  • 16
  • [ 20577-61-1 ]
  • [ 3405-77-4 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1942, vol. 72, p. 411,422
[2] Journal of the American Pharmaceutical Association (1912-1977), 1953, vol. 42, p. 594,597
  • 17
  • [ 19999-32-7 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1968, vol. 98, p. 203 - 209
  • 18
  • [ 300-87-8 ]
  • [ 4857-42-5 ]
Reference: [1] Russian Journal of Organic Chemistry, 1995, vol. 31, # 3, p. 386 - 389[2] Zhurnal Organicheskoi Khimii, 1995, vol. 31, # 3, p. 425 - 428
  • 19
  • [ 27930-43-4 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1942, vol. 72, p. 99,106
  • 20
  • [ 53009-77-1 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1942, vol. 72, p. 99,106
  • 21
  • [ 14716-89-3 ]
  • [ 70753-36-5 ]
  • [ 4857-42-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1939, vol. 69, p. 536,541
  • 22
  • [ 7647-01-0 ]
  • [ 3405-77-4 ]
  • [ 4857-42-5 ]
Reference: [1] Chemische Berichte, 1934, vol. 67, p. 638,640
[2] Diss. <Kiel 1899> S. 17, 29,
  • 23
  • [ 7803-49-8 ]
  • [ 615-79-2 ]
  • [ 3405-77-4 ]
  • [ 4857-42-5 ]
Reference: [1] Chemische Berichte, 1891, vol. 24, p. 3908[2] Chemische Berichte, 1909, vol. 42, p. 60
  • 24
  • [ 4857-42-5 ]
  • [ 64-17-5 ]
  • [ 63366-79-0 ]
Reference: [1] Patent: EP1894919, 2008, A1, . Location in patent: Page/Page column 23
  • 25
  • [ 4857-42-5 ]
  • [ 1380089-33-7 ]
Reference: [1] Patent: WO2016/97870, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4857-42-5 ]

Carboxylic Acids

Chemical Structure| 21169-71-1

[ 21169-71-1 ]

Isoxazole-5-carboxylic acid

Similarity: 0.87

Chemical Structure| 261350-46-3

[ 261350-46-3 ]

4-Methylisoxazole-5-carboxylic acid

Similarity: 0.84

Chemical Structure| 618383-47-4

[ 618383-47-4 ]

3-(4-Methoxyphenyl)isoxazole-5-carboxylic acid

Similarity: 0.77

Chemical Structure| 13626-60-3

[ 13626-60-3 ]

3-Hydroxyisoxazole-5-carboxylic acid

Similarity: 0.77

Chemical Structure| 6567-35-7

[ 6567-35-7 ]

3-Bromoisoxazole-5-carboxylic acid

Similarity: 0.75

Related Parent Nucleus of
[ 4857-42-5 ]

Isoxazoles

Chemical Structure| 63366-79-0

[ 63366-79-0 ]

Ethyl 3-methylisoxazole-5-carboxylate

Similarity: 0.89

Chemical Structure| 21169-71-1

[ 21169-71-1 ]

Isoxazole-5-carboxylic acid

Similarity: 0.87

Chemical Structure| 261350-46-3

[ 261350-46-3 ]

4-Methylisoxazole-5-carboxylic acid

Similarity: 0.84

Chemical Structure| 618383-47-4

[ 618383-47-4 ]

3-(4-Methoxyphenyl)isoxazole-5-carboxylic acid

Similarity: 0.77

Chemical Structure| 173850-41-4

[ 173850-41-4 ]

Ethyl isoxazole-5-carboxylate

Similarity: 0.77